Cronos (CRON) Revenue Growth (3y) (2021 - 2026)
Cronos (CRON) Revenue Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 2.22% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 4.22% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -0.31% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 9.51% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -1.40% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 28.43% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 8.98% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Cronos | 1.20 Bn | 407.87 Mn | 28.45 Mn | 39.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 39.87% |
| Mar 31, 2026 | 85.71% |
| Dec 31, 2025 | 45.12% |
| Sep 30, 2025 | 33.75% |
| Jun 30, 2025 | -26.41% |
| Mar 31, 2025 | -27.26% |
| Dec 31, 2024 | -35.13% |
| Sep 30, 2024 | 43.38% |
| Jun 30, 2024 | 35.28% |
| Mar 31, 2024 | 26.10% |
| Dec 31, 2023 | 24.74% |
| Sep 30, 2023 | 29.75% |
| Jun 30, 2023 | 37.69% |
| Mar 31, 2023 | -8.92% |
| Dec 31, 2022 | -98.06% |
| Sep 30, 2022 | 248.06% |
| Jun 30, 2022 | 52.41% |
| Mar 31, 2022 | 102.74% |
| Dec 31, 2021 | 14.72% |